Trial intelligence / Profile preview

STW 5-II in Functional Dyspepsia

NCT07198243Phase 4Not yet recruiting

Sponsor
UZ Leuven
Start
Sep 2025
Primary completion
Dec 2028
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of STW 5-II in functional dyspepsia (FD), sponsored by UZ Leuven. Planned start Sep 2025; status: not yet recruiting.

02

Drugs

STW 5-II
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on NCT07198243.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07198243.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call